GENEVA, July 27 -- KIM, Chul Geun filed a patent application (KR2025/022843) for “NOVEL MODIFIED PEPTIDE COMPOUND DERIVED FROM TRANSCRIPTION FACTOR CP2C COMPLEX FORMATION-REGULATING PEPTIDE (ACP52), EXHIBITING CANCER THERAPEUTIC ACTIVITY”. With publication no. WO/2026/155427, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C07D 207/16
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....